Trevi Therapeutics, Inc. (NASDAQ:TRVI) is held by 182 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 31 Mar, 2026 | 13,222,228 | 0 | 0.00% | $157,741,180.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 10,240,186 | 114,003 | 1.13% | $122,165,419.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 9,939,547 | -319,862 | -3.12% | $118,578,796.00 |
| FMR LLC | 31 Mar, 2026 | 8,038,061 | 1,538,052 | 23.66% | $95,894,063.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 5,189,088 | 1,785,098 | 52.44% | $61,905,820.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 5,094,668 | 0 | 0.00% | $60,779,389.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,978,567 | 4,978,567 | 0.00% | $59,394,304.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 3,966,019 | -614,529 | -13.42% | $47,314,607.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 3,712,373 | -54,376 | -1.44% | $44,288,610.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 3,298,430 | 11,343 | 0.35% | $39,350,270.00 |
| VIKING GLOBAL INVESTORS LP | 31 Mar, 2026 | 3,198,644 | 0 | 0.00% | $38,159,823.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 2,845,472 | -237,514 | -7.70% | $35,625,309.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,778,231 | 365,346 | 15.14% | $33,150,121.00 |
| State Street Corp | 31 Mar, 2026 | 2,665,313 | 230,313 | 9.46% | $31,797,184.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 2,622,306 | 0 | 0.00% | $31,284,111.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 2,454,400 | -736,300 | -23.08% | $29,280,992.00 |
| Logos Global Management LP | 31 Mar, 2026 | 2,400,000 | 850,000 | 54.84% | $28,632,000.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 2,166,504 | 2,166,504 | 0.00% | $25,846,393.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Mar, 2026 | 2,144,844 | 0 | 0.00% | $25,587,989.00 |
| Artia Global Partners LP | 31 Mar, 2026 | 2,013,602 | 0 | 0.00% | $24,022,272.00 |